Ellence
Generic name: Epirubicin
Drug class:
Antibiotics / antineoplastics
Usage of Ellence
Ellence is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Ellence is used to treat breast cancer.
Ellence may also be used for purposes not listed in this medication guide.
Ellence side effects
Get emergency medical help if you have signs of an allergic reaction to Ellence: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Epirubicin can cause dangerous effects on your heart that may not be reversible and could occur months to years after you receive Ellence. Call your doctor right away if you have symptoms of heart problems: swelling, rapid weight gain, shortness of breath.
Also call your doctor at once if you have:
Common Ellence side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Ellence
Before you are treated with Ellence, tell your doctor about all other cancer medications and treatments you have received, including radiation.
You should not use Ellence if you are allergic to epirubicin or similar medications (such as daunorubicin, doxorubicin, idarubicin,mitoxantrone, or valrubicin), or if you have:
You may not be able to use Ellence if you have already been treated with a certain amount of other cancer medications.
To make sure Ellence is safe for you, tell your doctor if you have ever had:
Using Ellence may increase your risk of developing other cancers, such as leukemia. Ask your doctor about this risk.
Both men and women using this medicine should use effective birth control to prevent pregnancy. Epirubicin can harm an unborn baby if the mother or father is using this medicine.
Epirubicin may cause you to stop having menstrual periods and may also cause premature menopause. Talk with your doctor if you have concerns about these risks.
You should not breastfeed while using Ellence.
Relate drugs
- Adriamycin
- Cosmegen
- Mutamycin
- Blenoxane
- Bleomycin
- Cerubidine
- Dactinomycin
- Daunorubicin
- Daunorubicin citrate liposome
- Daunoxome
- Doxil
- Doxorubicin
- Doxorubicin liposomal
- Doxorubicin liposome
- Ellence
- Epirubicin
- Idamycin PFS
- Idarubicin
- Jelmyto
- Jelmyto gel
- Mitomycin
- Mitomycin (Injection)
- Mitomycin (Intravenous)
- Mitomycin gel
- Mitoxantrone
- Nipent
- Novantrone
- OTN Mitoxantrone
- Pentostatin
- Plicamycin
- Valrubicin
- Valstar
How to use Ellence
Usual Adult Dose for Breast Cancer -- Adjuvant:
Initial dose: 100 to 120 mg/m2 IV in repeated 3- to 4-week cycles; either total dose on Day 1 of each cycle, or divided equally and given on Days 1 and 8 of each cycle CEF-120 regimen (repeat every 28 days for 6 cycles): -Cyclophosphamide: 75 mg/m2 orally on Days 1 to 14 -Epirubicin: 60 mg/m2 IV on Days 1 and 8 -5-Fluorouracil: 500 mg/m2 IV on Days 1 and 8 FEC-100 regimen (repeat every 21 days for 6 cycles): -5-Fluorouracil: 500 mg/m2 IV on Day 1 -Epirubicin: 100 mg/m2 IV on Day 1 -Cyclophosphamide: 500 mg/m2 IV on Day 1 Recommended infusion rates: -For starting doses of 100 to 120 mg/m2, give the infusion over 15 to 20 minutes. -For patients who require lower starting doses due to organ dysfunction or who require modification of doses during therapy, the infusion time may be proportionally decreased, but should not be less than 3 minutes to minimize the risk of thrombosis or perivenous extravasation, which could lead to severe cellulitis, vesication, or tissue necrosis. -A direct push injection is not recommended due to the risk of extravasation, which may occur even in the presence of adequate blood return upon needle aspiration. Venous sclerosis may result from injection into small vessels or repeated injections into the same vein. Comments: -Doses are manufacturer suggested. Consult local protocol. -Consider use of antiemetics when given in conjunction with other emetogenic drugs. -Patients administered the 120 mg/m2 regimen should receive prophylactic antibiotics. Use: As adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer
Warnings
You should not use Ellence if you have an untreated or uncontrolled infection, severe liver disease, severe heart problems, or if you have recently had a heart attack. You may not be able to use Ellence if you have already been treated with a certain amount of other cancer medications.
Tell your caregivers if you feel any burning, pain, or swelling around the needle when Ellence is injected.
Ellence can cause dangerous effects on your heart that may not be reversible and could occur months to years after you receive Ellence. Call your doctor right away if you have symptoms of heart problems: swelling, rapid weight gain, shortness of breath.
Ellence affects your immune system. You may get infections more easily, even serious or fatal infections. You will need frequent medical tests and your cancer treatments may be delayed.
What other drugs will affect Ellence
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with epirubicin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions